Cystinuria: clinical practice recommendation
Cystinuria: clinical practice recommendation (Published 2020) DOWNLOAD PDF HERE
Cystinuria: clinical practice recommendation (Published 2020) DOWNLOAD PDF HERE
A grateful couple are undertaking a Christmas charity challenge to say thank you to a hospital that provided care for their son. By Stephanie Bateman Wednesday, 16th December 2020, 11:57 am NOTE: See Full Story at THE STAR Clare and Tom Law are taking part in the National Elf Service, a festive fundraiser when charity [...]
2020 - Update on cystine stones: current and future concepts in treatment Visit the IRDR site and original article here Download PDF Here Summary Cystine stones are relatively uncommon compared with other stone compositions, constituting just 1% to 2% of adult urinary tract stone diseases, and accounting for up to 10% of pediatric [...]
Case Study - Case Studies in Cystinuria DOWNLOAD PDF HERE
Coronavirus News: COVID-19 increases urgency for Tablo Hemodialysis Systems "We think 30% of ICU patients are developing acute kidney injury," said Dr. David Goldfarb, Chief of Nephrology at New York Harbor VA Medical Center. Dr. Goldfarb said he could not predict this kind of system failure that occurred with patients infected with the [...]
New Formulation of Tiopronin Receives FDA Approval for Treatment of Cystinuria Officials with the FDA have approved a new enteric-coated formulation of tiopronin (Thiola EC, Retrophin) 100 mg and 300 mg tablets, for the treatment of cystinuria, a rare inherited disorder that causes a buildup of cystine levels in the urine, resulting in [...]
α-Lipoic Acid (ALA) Improves Cystine Solubility in Cystinuria: Report of 2 Cases A recent study revealed efficacy of nutritional supplement α-lipoic acid (ALA) treatment in preventing kidney stones in a mouse model of cystinuria. Here, we report 2 pediatric patients (6 and 15 years old) with cystinuria who received regular doses of ALA [...]
Retrophin Announces FDA Approval of THIOLA® EC (tiopronin) 100mg and 300mg Tablets Retrophin, Inc. (NASDAQ: RTRX) today announced that the U.S. Food and Drug Administration (FDA) has approved 100 mg and 300 mg tablets of THIOLA® EC (tiopronin), a new enteric-coated formulation of THIOLA® (tiopronin), to be used for the treatment of cystinuria, a [...]